Clinical Trial Update: Effect of Rhopressa on Intraocular Pressure (IOP) in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension Post-SLT [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating Rhopressa (netarsudil) for lowering intraocular pressure in adults with primary open-angle glaucoma or ocular hypertens…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• RHOPRESSA (NETARSUDIL)

Snippet

Sponsor: East Coast Institute for Research | Conditions: Primary Open Angle Glaucoma or Ocular Hypertension | Phase 4 | Status: RECRUITING